论文部分内容阅读
据2013年4月15日《科技日报》报道,美国斯坦福-伯纳姆医学研究所的研究人员发现,一种名为PKCzeta的酶能够抑制前列腺肿瘤的形成,并在实验鼠和人体中同时得到了验证。此外,该研究还描述了一条控制肿瘤细胞生长和转移的分子通路。这一发现是前列腺癌治疗领域的一项重大进展,有助于科学家开发新的方法来控制肿瘤的发展。相关论
According to the April 15, 2013 Science and Technology Daily report, researchers at the Stanford-Burnham Institute of Medicine in the United States found that an enzyme called PKCzeta can inhibit the formation of prostate tumors and is obtained in both experimental mice and humans Verified. In addition, the study describes a molecular pathway that controls tumor cell growth and metastasis. This finding is a major advance in the treatment of prostate cancer and helps scientists develop new ways to control tumor progression. Related theory